These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Individualized therapy with alpha-interferon in metastatic renal cell carcinoma].
    Author: Gross AJ, Dieckmann KP, Krain J, Huland H.
    Journal: Urologe A; 1995 Mar; 34(2):158-61. PubMed ID: 7754588.
    Abstract:
    Thirty-two patients with metastatic renal cell carcinoma were treated as outpatients with individually dosed interferon alpha (IFN alpha). The individual maximum dose was based on the side effects. In 7 patients the course of the disease was influenced: 1 attained complete remission, 3 patients, partial remission and 3, stable disease. The outcome of therapy was not dose-dependent. Patients with lung metastases were more sensitive to IFN alpha than the others. Up to 20% of patients responded to the therapy.
    [Abstract] [Full Text] [Related] [New Search]